These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33470307)

  • 1. Chagas Cardiomyopathy as the Etiology of Suspected Coronary Microvascular Disease. A Comparison Study with Suspected Coronary Microvascular Disease of Other Etiologies.
    Campos FA; Magalhães ML; Moreira HT; Pavão RB; Lima Filho MO; Lago IM; Badran AV; Chierice JRA; Schmidt A; Marin Neto JA
    Arq Bras Cardiol; 2020 Dec; 115(6):1094-1101. PubMed ID: 33470307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between coronary microvascular dysfunction (CMD) and left ventricular diastolic function in patients with symptoms of myocardial ischemia with non-obstructive coronary artery disease (INOCA) by cardiovascular magnetic resonance feature-tracking.
    Kong H; Cao J; Tian J; Yong J; An J; Song X; He Y
    Clin Radiol; 2024 Jul; 79(7):536-543. PubMed ID: 38679491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and angiographic characteristics of coronary microvascular dysfunction in stable angina: a hybrid imaging study.
    Stenström I; Maaniitty T; Uusitalo V; Pietilä M; Ukkonen H; Kajander S; Mäki M; Bax JJ; Knuuti J; Saraste A
    Eur Heart J Cardiovasc Imaging; 2017 Nov; 18(11):1206-1213. PubMed ID: 28950300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial tissue deformation is reduced in subjects with coronary microvascular dysfunction but not rescued by treatment with ranolazine.
    Nelson MD; Sharif B; Shaw JL; Cook-Wiens G; Wei J; Shufelt C; Mehta PK; Thomson LEJ; Berman DS; Thompson RB; Handberg EM; Pepine CJ; Li D; Bairey Merz CN
    Clin Cardiol; 2017 May; 40(5):300-306. PubMed ID: 28004395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary microvascular dysfunction and myocardial contractile reserve in women with angina and no obstructive coronary artery disease.
    Michelsen MM; Pena A; Mygind ND; Bech J; Gustafsson I; Kastrup J; Hansen HS; Høst N; Hansen PR; Prescott E
    Echocardiography; 2018 Feb; 35(2):196-203. PubMed ID: 29222822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin plus verapamil relieves angina and perfusion abnormalities in patients with coronary microvascular dysfunction and Chagas disease: a pilot non-randomized study.
    Pavão RB; Moreira HT; Pintya AO; Haddad JL; Badran AV; Lima-Filho MO; Lago IM; Chierice JRA; Schmidt A; Marin-Neto JA
    Rev Soc Bras Med Trop; 2021; 54():e0181. PubMed ID: 34787258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing planned versus ad hoc coronary microvascular assessment: Early findings from the Coronary Microvascular Disease Registry.
    Merdler I; Bazarbashi N; Medranda GA; Zhang C; Ozturk ST; Sawant V; Ben-Dor I; Waksman R; Hashim HD; Case BC
    Cardiovasc Revasc Med; 2024 Oct; 67():69-74. PubMed ID: 38724408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Regional Left Ventricular Strain in Patients with Chagas Disease and Normal Left Ventricular Systolic Function.
    Gomes VA; Alves GF; Hadlich M; Azevedo CF; Pereira IM; Santos CR; Brasil PE; Sangenis LH; Cunha AB; Xavier SS; Saraiva RM
    J Am Soc Echocardiogr; 2016 Jul; 29(7):679-88. PubMed ID: 27086044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of echocardiographic measures of left ventricular diastolic dysfunction and hypertrophy with presence of coronary microvascular dysfunction.
    Dykun I; Kärner L; Mahmoud I; Hendricks S; Totzeck M; Al-Rashid F; Rassaf T; Mahabadi AA
    Int J Cardiol Heart Vasc; 2020 Apr; 27():100493. PubMed ID: 32154362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary microvascular dysfunction: prevalence and aetiology in patients with suspected myocardial ischaemia.
    Kong H; Cao J; Tian J; Yong J; An J; Zhang L; Song X; He Y
    Clin Radiol; 2024 May; 79(5):386-392. PubMed ID: 38433042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary microvascular disease: The "Meeting Point" of Cardiology, Rheumatology and Endocrinology.
    Markousis-Mavrogenis G; Bacopoulou F; Mavragani C; Voulgari P; Kolovou G; Kitas GD; Chrousos GP; Mavrogeni SI
    Eur J Clin Invest; 2022 May; 52(5):e13737. PubMed ID: 34939183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary microvascular dysfunction is associated with cardiac time intervals in women with angina and no obstructive coronary artery disease: An iPOWER substudy.
    Pena A; Michelsen MM; Mygind ND; Gustafsson I; Høst N; Bech J; Kastrup J; Hansen HS; Hansen PR; Prescott E
    Echocardiography; 2019 Jun; 36(6):1110-1117. PubMed ID: 31012159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary microvascular dysfunction assessment: A comparative analysis of procedural aspects.
    Merdler I; Wallace R; Banerjee A; Medranda GA; Reddy P; Cellamare M; Zhang C; Ozturk ST; Sawant V; Lopez K; Ben-Dor I; Waksman R; Case BC; Hashim HD
    Catheter Cardiovasc Interv; 2024 Apr; 103(5):703-709. PubMed ID: 38520176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI).
    Nunes MCP; Badano LP; Marin-Neto JA; Edvardsen T; Fernández-Golfín C; Bucciarelli-Ducci C; Popescu BA; Underwood R; Habib G; Zamorano JL; Saraiva RM; Sabino EC; Botoni FA; Barbosa MM; Barros MVL; Falqueto E; Simões MV; Schmidt A; Rochitte CE; Rocha MOC; Ribeiro ALP; Lancellotti P
    Eur Heart J Cardiovasc Imaging; 2018 Apr; 19(4):459-460n. PubMed ID: 29029074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current perspectives in coronary microvascular dysfunction.
    Shome JS; Perera D; Plein S; Chiribiri A
    Microcirculation; 2017 Jan; 24(1):. PubMed ID: 27976459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular concentric remodelling and functional impairment in women with ischaemia with no obstructive coronary artery disease and intermediate coronary flow reserve: a report from the WISE-CVD study.
    Park SM; Wei J; Cook-Wiens G; Nelson MD; Thomson L; Berman D; Handberg E; Petersen J; Anderson D; Pepine CJ; Merz CNB
    Eur Heart J Cardiovasc Imaging; 2019 Aug; 20(8):875-882. PubMed ID: 30904924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas' cardiomyopathy.
    Simões MV; Pintya AO; Bromberg-Marin G; Sarabanda AV; Antloga CM; Pazin-Filho A; Maciel BC; Marin-Neto JA
    Am J Cardiol; 2000 Nov; 86(9):975-81. PubMed ID: 11053710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary microvascular dysfunction, microvascular angina, and treatment strategies.
    Marinescu MA; Löffler AI; Ouellette M; Smith L; Kramer CM; Bourque JM
    JACC Cardiovasc Imaging; 2015 Feb; 8(2):210-20. PubMed ID: 25677893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients With Nonobstructive Coronary Artery Disease: Systematic Review and Meta-Analysis.
    Mileva N; Nagumo S; Mizukami T; Sonck J; Berry C; Gallinoro E; Monizzi G; Candreva A; Munhoz D; Vassilev D; Penicka M; Barbato E; De Bruyne B; Collet C
    J Am Heart Assoc; 2022 Apr; 11(7):e023207. PubMed ID: 35301851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional Myocardial Perfusion Disturbance in Experimental Chronic Chagas Cardiomyopathy.
    Lemos de Oliveira LF; Thackeray JT; Marin Neto JA; Dias Romano MM; Vieira de Carvalho EE; Mejia J; Tanaka DM; Kelly da Silva G; Abdalla DR; Malamut C; Bengel FM; de Lourdes Higuchi M; Schmidt A; Cunha-Neto E; Simões MV
    J Nucl Med; 2018 Sep; 59(9):1430-1436. PubMed ID: 29700129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.